After opening in the green, the Indian indices are trading flat during the morning session amid outperformance in pharma stocks. Engineering and energy stocks are leading the losers today.
The BSE-Sensex is trading up 34 points. The NSE-Nifty is trading up 13 points. The BSE Mid Cap index is trading up 0.3% and the BSE Small Cap index is trading up 0.1%. The rupee is trading at 62.12 to the US dollar.
Most software stocks are trading higher today. Wipro and Tata Consultancy Services (TCS) are leading the gainers. As per a leading financial daily, India's fifth largest IT firm Tech Mahindra, has launched a data analysis platform for auto insurance firms. The software will allow these firms to adjust premiums according to the actual usage patterns of individual drivers. This is a big improvement to the existing system of using industry averages to calculate premiums. Tech Mahindra claims that this solution will help insurers reduce claim costs by up to 20% and premiums by up to 40%. Tech Mahindra has begun marketing the product across geographies with AT&T providing global connectivity for the software. Tech Mahindra was trading up 0.3% at the time of writing.
As per a leading business daily, recently out macro economic data shows that the pace of activity at factories in the country expanded at the fastest pace in almost 2 years during the month of November on the back of rising order books. The rising orders are leading manufacturers to increase output. The Purchasing Managers' Index (PMI) compiled by HSBC rose to 53.3 in November from 51.6 in October. This is its highest level since February 2013. The related survey also revealed that companies have been able to pass on additional input costs to consumers at a faster clip during the month gone by, which bodes well for the earnings of corporate India going forward.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Equitymaster requests your view! Post a comment on "Pharma stocks outperform". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!